UBTF and ovarian carcinoma: Incorporating the somatic mutations in non-coding regions revealed a slightly broader spectrum of findings, of which potentially significant discoveries include UBTF in Ovarian Cancer (OV) and ACTBL2 in HNSC (S6 Table).